Randomized trial of low-dose misoprostol and naproxen vs. nabumetone to prevent recurrent upper gastrointestinal haemorrhage in users of non-steroidal anti-inflammatory drugs

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 1, 2001, Pages 19-24

  Chan, F K L ^a,b   Sung, J J Y ^a   Ching, J Y L ^a   Wu, J C Y ^a   Lee, Y T ^a   Leung, W K ^a   Hui, Y ^a   Chan, L Y ^a   Lai, A C W ^a   Chung, S C S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH MUCOSA; STOMACH ULCER;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUTANONES; DRUG THERAPY, COMBINATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MISOPROSTOL; NAPROXEN; PROSPECTIVE STUDIES; RECURRENCE;

EID: 0035176303     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.00890.x     Document Type: Article

References (27)

1. Epidemiology of NSAID induced gastrointestinal complications
2. NSAID gastropathy: The second most deadly rheumatic disease? Epidemiology and risk appraisal
3. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: A randomized, double-blind, placebo-controlled trial
4. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology
5. Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: A comparison of three regimens
6. Misoprostol coadministered with diclofenanc for prevention of gastroduodenal ulcers: A one year study
7. Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis
8. A controlled study comparing the effects of nabumetone, ibuprofen, and ibuprofen and ibuprofen plus misoprostol on the upper gastrointestinal tract mucosa
9. A long-term endoscopic evaluation of patients with arthritis treated with nabumetone vs naproxen
10. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: A meta-analysis
11. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs
12. Randomised trial of eradication of Helicobacter pylori before starting non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers
13. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study
14. Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly
15. Prospective randomized trial of H. pylori eradication versus maintenance omeprazole to prevent recurrent upper gastrointestinal hemorrhage in high-risk aspirin and non-aspirin NSAID users
16. An overview of the key role of misoprostol in the prophylaxis of NSAID-associated ulcers and their complications
17. Improving the gastrointestinal safety of NSA-IDs. The development of misoprostol - From hypothesis to clinical practice
18. Diclofenac/Misoprostol: Novel findings and their clinical potential
19. NSAID-induced gastrointestinal damage: A critical review of prophylaxis and therapy
20. Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial
21. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: A prospective, double-blind, multicenter study
22. The prevention and healing of acute non-steroidal anti-inflammatoy drug-associated gastroduodenal mucosal damage by misoprostol
23. The gastroduodenal safety and efficacy of the fixed combination of diclofenac and misoprostol in the treatment of osteoarthritis
24. Double-blind comparison of efficacy and safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis
25. A double-blind comparison of the gastroduodenal safety and efficacy of diclofenac and a fixed dose combination of diclofenac and misoprostol in the treatment of rheumatoid arthritis
26. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study
27. Gastrointestinal bleeding in patients treated with nabumetone or indomethacin